Ironwood Pharmaceuticals (NASDAQ: IRWD) reported Q4 EPS of ($0.27), $0.06 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $38.1 million versus the consensus estimate of $35.2 million.

For earnings history and earnings-related data on Ironwood Pharmaceuticals (IRWD) click here.